Skip to main content

Table 1 Hepatic content of reduced glutathione (GSH) and malondialdehyde (MDA)

From: The effect of co-administration of Lawsonia inermis extract and octreotide on experimental hepatocellular carcinoma

Parameter

Group

Normal control (N)

DENA control (D)

Lawsonia (L)

Octreotide (O)

Octreotide + lawsonia (L + O)

GSH content (µM/500 mg) wet tissue

3.3 ± 0.2

1.311 ± 0.08727a

2.188  ± 0.0999a

1.804  ± 0.1309b

2.758 ± 0.1033a

MDA content (µM/500 mg) wet tissue

29.1 ± 1.7

148.6 ± 9.8a

92.85  ± 8.9a

113.6  ± 8.6b

54.08 ± 5a

  1. Data are presented as mean ± SE, n = 10, multiple comparisons were done using one-way ANOVA followed by Tukey–Karmer as post ANOVA test
  2. D DENA, L LIE, O OC, L + O LIE + OC
  3. aHighly significantly different from corresponding control at P < 0.001
  4. bSignificantly different from control group at P < 0.05, D group was compared to normal control, L, O and L + O groups were compared to DENA control
Back to article page

Environmental Health and Preventive Medicine

ISSN: 1347-4715

Contact us